{{Drugbox
| Watchedfields = changed
| verifiedrevid = 444392593
| IUPAC_name = (6''R'',7''R'')-8-oxo-7-{[2-(tetrazol-1-yl)acetyl]amino}-<br>3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-<br>1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic&nbsp;acid
| image = ceftezole.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 26973-24-0
| ATC_prefix = J01
| ATC_suffix = DB12
| ChEMBL = 1697829
| PubChem = 65755
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 59178
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2Z86SYP11W
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07656

<!--Chemical data-->
| C=13 | H=12 | N=8 | O=4 | S=3 
| molecular_weight = 440.484 g/mol
| smiles = O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)Cn3nnnc3)CSc4nncs4)C(=O)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H12N8O4S3/c22-7(1-20-4-14-18-19-20)16-8-10(23)21-9(12(24)25)6(2-26-11(8)21)3-27-13-17-15-5-28-13/h4-5,8,11H,1-3H2,(H,16,22)(H,24,25)/t8-,11-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DZMVCVMFETWNIU-LDYMZIIASA-N
}}

'''Ceftezole''' (or '''ceftezol''') is a [[cephalosporin]] [[antibiotic]].


{{antibiotic-stub}}

{{CephalosporinAntiBiotics}}

[[Category:Cephalosporin antibiotics]]
[[Category:Enantiopure drugs]]
[[Category:Thiadiazoles]]
[[Category:Tetrazoles]]